Treatment for IE Flashcards
Highly susceptible streptococci in native valve
PCN G (12-18 units/day) OR ceftriaxone 2g/day for 4 wks OR PCN + Gent for 2 wks or Ceftriaxone + Gent for 2 wks
Highly susceptible strept in prosthetic valve
PCN G (24 units/day) OR ceftriaxone 2g/day
and mandatory 2 wk course gentamicin
DoT: 6 wks
Relatively resistant Strept in native valve
PCN G (24 units/ 24 hr) OR ceftriaxone 2g/day
+ mandatory 2 wk course gentamicin
DoT: 4 wk
Relatively resistant strept in prosthetic valve
PCN G (24 units/24 hr) OR ceftriaxone 2g/24 hr
and mandatory 6 wk course gentamicin
DoT: 6 wk
Highly resistant strept in native valve
ampicillin (12g/ 24 hr) OR PCN G (18-30 units/day) + 4-6 wk gentamicin or ceftriaxone
DoT: 4-6 wk
Highly resistant strept in prosthetic valve
ampicillin (12g/ 24 hr) OR PCN G (18-30 units/day) + 4-6 wk gentamicin or ceftriaxone
DoT: 6 wk or longer
Enterococci susceptible in native or prosthetic
ampicillin (12g/ 24 hr) OR PCN G (18-30 units/day) + 4-6 wk gentamicin or ceftriaxone
DoT: 6 wk or longer
Enterococci B-lactam resistant of native or prosthetic valve
Linezolid, quinupristin/dalfoprisitn, daptomycin
Methicillin Susceptible Staph (MSSA) native valves
nafcillin (12g/ 24 hr)
alternative: cefazolin
DoT: 6 wk
Methicillin Susceptible Staph (MSSA) prosthetic valves
nafcillin + rifampin (900 mg/24 hr) + 2 wk gentamicin
DoT: 6 wk or longer
Methicillin resistant Staph (MRSA) native valves
Vancomycin
alternative: daptomycin
DoT: 6 wk
Methicillin resistant Staph (MRSA) prosthetic valves
vancomycin + rifampin (900 mg/24hr) + 2 wk gentamicin
DoT: 6 wk or longer